AI Assistant
Blog
Pricing
Log In
Sign Up
Inotuzumab ozogamicin is deliverable in relapsed ALL patients with end-stage renal disease on hemodialysis
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
